Pei-Jer Chen

31PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jan 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease.

Yu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng

|Nov 14, 2025
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee

|Nov 11, 2025
The combination of ropeginterferon alfa-2b with anti-PD1 blockage in adjuvant therapy in HBV-related HCC.

Albert Qin, Ming-Chih Ho, Chan-Yen Tsai

|Jun 20, 2025
Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold.

Tai-Chung Tseng, Shang-Chin Huang, Mei-Hung Pan

|Apr 05, 2025
Sequential combination with ropeginterferon alfa-2b and anti-PD-1 treatment as adjuvant therapy in HBV-related HCC: a phase 1 dose escalation trial.

Albert Qin, Ming-Chih Ho, Chan-Yen Tsai

|Jan 01, 2025
HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC.

Chiao-Ling Li, Chia-Lang Hsu, You-Yu Lin

Pageof 6

Frequent Collaborators

11 joint publications

Jia-Horng Kao

8 joint publications

Tung-Hung Su

7 joint publications

Chen-Hua Liu

6 joint publications

Chun-Jen Liu